A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

[1]  F. Real,et al.  Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.

[2]  G. Zamboni,et al.  The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma , 2001, The American journal of surgical pathology.

[3]  M. Lerch,et al.  Autocrine Stimulation of Human Pancreatic Duct–Like Development by Soluble Isoforms of Epimorphin in Vitro , 2001, The Journal of cell biology.

[4]  F. Sarkar,et al.  Colloid (Mucinous Noncystic) Carcinoma of the Pancreas , 2001, The American journal of surgical pathology.

[5]  G. Klöppel,et al.  The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation , 2000, The Journal of pathology.

[6]  N. Lemoine,et al.  Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki‐ras mutations provides evidence of a ductal origin , 1998, The Journal of pathology.

[7]  Kathleen R. Cho,et al.  DPC4 gene in various tumor types. , 1996, Cancer research.

[8]  W. Schmiegel,et al.  Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. , 1996, Gastroenterology.

[9]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[10]  J. Lloreta,et al.  New pancreas cancers cell lines that represent distinct stages of ductal differentiation. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[11]  F. Real,et al.  Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer , 1994, International journal of cancer.

[12]  K. Herzig,et al.  Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. , 1994, Gastroenterology.

[13]  M. Hollingsworth,et al.  Expression of MUC1, MUC2, MUC3 and MUC4 mucin mrnas in human pancreatic and intestinal tumor cell lines , 1994, International journal of cancer.

[14]  C. Balagué,et al.  Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. , 1994, Gastroenterology.

[15]  M. Löhr,et al.  Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. , 1994, British Journal of Cancer.

[16]  G. Lauer,et al.  p53 and K-RAS alterations in pancreatic epithelial cell lesions. , 1993, Oncogene.

[17]  R. Bresalier,et al.  Characterization of the Cytokeratins of Human Colonic, Pancreatic, and Gastric Adenocarcinoma Cell Lines , 1992, Pancreas.

[18]  F. Ramaekers,et al.  Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. , 1992, The American journal of pathology.

[19]  P. Hall,et al.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. , 1991, British Journal of Cancer.

[20]  E. Heyderman,et al.  Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2. , 1990, Journal of clinical pathology.

[21]  H. Kern,et al.  Fine Structure of Three Major Grades of Malignancy of Human Pancreatic Adenocarcinoma , 1987, Pancreas.

[22]  H. Kern,et al.  Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases , 1985, Histopathology.

[23]  Y. Anraku,et al.  Activation of the c-K-ras oncogene in a human pancreas carcinoma. , 1985, Biochemical and biophysical research communications.

[24]  M. D. Turner,et al.  "COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice. , 1983, Cancer research.

[25]  N. Yamaguchi,et al.  Establishment and characterization of a carcinoembryonic antigen (CEA)‐producing cell line from a human carcinoma of the exocrine pancreas , 1983, Cancer.

[26]  M. Borowitz,et al.  Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. , 1982, Cancer research.

[27]  M. Rao,et al.  Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics. , 1982, The American journal of pathology.

[28]  G. Moore,et al.  Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma , 1980, International journal of cancer.

[29]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[30]  A. Yunis,et al.  Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase , 1977, International journal of cancer.

[31]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[32]  G. Martinelli,et al.  Expression of intermediate filaments in normal and neoplastic exocrine pancreas. , 1994, Zentralblatt fur Pathologie.

[33]  M. H. Tan,et al.  Characterization of a new primary human pancreatic tumor line. , 1986, Cancer investigation.